Cambridge Investment Research Advisors
APEN

Cambridge Investment Research Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,147
Closed -$67K – 3263
2022
Q1 		$67K Buy
+11,147
New +$67.9K ﹤0.01% 3058

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Cambridge Investment Research Advisors's APEN Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2022, closing a stake of 11,147 shares — an estimated $67K sold.

Cambridge Investment Research Advisors first reported a position in APEN in Q1 2022 and held it in 1 quarter. The position peaked at $67K in Q1 2022. 63 funds tracked by Wall St. Rank hold APEN as of Q2 2022.

  • Cambridge Investment Research Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q2 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,147 Apollo Endosurgery, Inc. shares in Q2 2022, an estimated $67K.
  • Cambridge Investment Research Advisors first reported a position in Apollo Endosurgery, Inc. in Q1 2022 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Apollo Endosurgery, Inc. position peaked at $67K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.